Emergent BioSolutions Inc. — Director's Dealing 2017

Jul 21, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-07-20

Reporting Person: Strei Katherine (EVP, Chief HR Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1088	Direct
Common Stock	8852	Direct

Footnotes

F1: These shares of common stock result from the prior vesting of a restricted stock unit award.

F2: Consists of restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended and restated.

F3: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date.